APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 69 filers reported holding APPLIED GENETIC TECHNOL CORP in Q4 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | +66.7% | 20,259 | +368.7% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 4,322 | -5.8% | 0.00% | – |
| Q4 2021 | $8,000 | -91.7% | 4,586 | -76.8% | 0.00% | – |
| Q3 2020 | $96,000 | +1500.0% | 19,796 | +1152.9% | 0.00% | – |
| Q1 2019 | $6,000 | +200.0% | 1,580 | +48.5% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 1,064 | +354.7% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 234 | -55.3% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 524 | -45.2% | 0.00% | – |
| Q4 2017 | $3,000 | – | 957 | +6280.0% | 0.00% | – |
| Q1 2017 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |